Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

AtriCure, Inc. (ATRC)

$58.97 -0.56% NASDAQ: ATRC · 15-min delayed
  • MASON, Ohio
  • Public · NASDAQ: ATRC
  • 1,350 employees
$1.8BMarket cap
$534.5MRevenue · FY2025
-$11.4MNet income
1,350Employees
ATRCNASDAQ
2005IPO

About AtriCure, Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$534.5M
Net income
-$11.4M
Total assets
$654.2M
Market cap
$1.8B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ATRC
$58.97 -0.56%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$25.86 $60.77

52-week range

Market cap
$1.8B
Shares outstanding
30.1M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Aug 5, 2005

AtriCure, Inc. (ATRC) Stock Price

  • Reported a net loss of $11.4M in FY2025.
  • Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review AtriCure, Inc..

Write a review
Newsroom

News about AtriCure, Inc.

News & sentiment via Polygon.io

FAQ

AtriCure, Inc.: frequently asked questions

Is AtriCure, Inc. an American company?

AtriCure, Inc. is a US-based company headquartered in Mason, Ohio, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is AtriCure, Inc. headquartered?

AtriCure, Inc. is headquartered in Mason, Ohio, United States.

Is AtriCure, Inc. publicly traded?

Yes — AtriCure, Inc. is a publicly traded company. Its stock trades under the ticker symbol ATRC on the NASDAQ.

What does AtriCure, Inc. do?

AtriCure, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →